ST
ECYT

Spot Trading’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Spot Trading’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,600
Closed -$16K – 4600
2014
Q3 		$16K Sell
2,600
-70,200
-96% -$479K ﹤0.01% 3992
2014
Q2 		$480K Buy
72,800
+55,000
+309% +$620K ﹤0.01% 2727
2014
Q1 		$424K Buy
+17,800
New +$258K ﹤0.01% 2668

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spot Trading's ECYT Position: Q4 2014 in Review

Spot Trading sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2014, closing a stake of 21,409 shares — an estimated $130K sold.

Spot Trading first reported a position in ECYT in Q2 2013 and held it in 3 quarters. The position peaked at $130K in Q3 2014. 100 funds tracked by Wall St. Rank hold ECYT as of Q4 2014.

  • Spot Trading reported no remaining Endocyte, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Spot Trading sold 21,409 Endocyte, Inc. Common Stock shares in Q4 2014, an estimated $130K.
  • Spot Trading first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • Spot Trading's Endocyte, Inc. Common Stock position peaked at $130K in Q3 2014.
  • 100 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.